Fig. 2
From: Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma
Comparison of overall survival times between clinical and pathological features. A: among four groups, B: N stage, C: stage, D: pleural invasion, E: carcinothrombosis, F: STAS, G: lepidic component, H: solid component, I: micropapillary component, J: CT manifestation, K: PD-L1 level